MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $444,692 | -31.1% | 3,045 | +8.9% | 0.21% | -30.4% |
Q2 2023 | $645,876 | -4.6% | 2,796 | 0.0% | 0.30% | -46.4% |
Q1 2023 | $677,359 | +9.4% | 2,796 | -70.7% | 0.55% | +55.9% |
Q3 2022 | $619,000 | +79.9% | 9,527 | +98.5% | 0.35% | +70.2% |
Q2 2022 | $344,000 | -22.5% | 4,800 | +6.1% | 0.21% | -26.2% |
Q1 2022 | $444,000 | – | 4,525 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |